Markets /Healthcare /KITE Kite Pharma, Inc. KITE Full chart Compare Add to watchlist Set alert Price alert · KITE Alert when the price is Price abovePrice below Price level Set alert All alert types No live quote for KITE yet. Overview Chart Financials FinancialsValuation & healthEarnings EarningsDividends & splitsAnalysts News Ownership Options More ComparisonSignalsTrend ScoreDiscussionNotesPositionsAlerts FinancialsValuation & health Revenue history · Free cash flow history OverviewIncome statementBalance sheetCash flow Revenue & Expenses AnnualQuarterly FY 2016FY 2015 Other Income → Expenses: $3.24MIncome Tax Benefit → Expenses: $2.89MExpenses → Selling, General & Admin: $97.42MExpenses → Research & Development: $197.93MExpenses → Interest Expense: $13.00KGross Profit → Expenses: $22.17MRevenue → Gross Profit: $22.17MNet Loss → Expenses: $267.07MOther Income$3.24MIncome Tax Benefit$2.89MGross Profit$22.17MNet Loss$267.07MExpenses$295.37MSelling, General & Admin$97.42MResearch & Development$197.93MInterest Expense$13.00KRevenue$22.17M Latest period ending Dec 31, 2016 · select a line to chart its full history Income statement Full income statement How to read it KITE annual income statementFiscal yearFY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012Total Revenue22.17M17.26M000 Gross Profit22.17M17.26M000 Operating Income-273.19M-103.95M-36.66M-6.43M-2.58M Net Income-267.07M-101.65M-42.57M-6.37M-2.57M Earnings per Diluted Share-5.46-2.33-1.91-1.43-0.48 Balance sheet Full balance sheet How to read it KITE annual balance sheetFiscal yearFY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012Cash and Equivalents125.23M394.38M209.30M22.36M8.65M Total Assets524.30M707.96M370.75M22.98M8.89M Total Liabilities96.33M92.20M8.16M1.40M1.05M Shareholders Equity427.97M615.76M362.59M21.58M7.85M Cash flow Full cash flow How to read it KITE annual cash flowFiscal yearFY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012Net Cash Flow from Operations-168.90M-19.03M-17.07M-5.61M-2.79M Net Cash Flow from Investing-112.94M-106.54M-160.14M-279.00K-2.00K Net Cash Flow from Financing3.69M309.07M364.15M19.60M255.00K Capital Expenditure-20.15M-26.57M-2.10M-279.00K-2.00K Net Cash Flow / Change in Cash & Cash Equivalents-278.28M183.54M186.94M13.71M-2.53M
